Award-winning research paves the way for animal-free cell culture

Maria Karlgren, forskare vid Uppsala universitet

New research shows that cells cultured using non-animal methods produce reproducible results in studies of intestinal drug absorption. “This provides a high-quality alternative to foetal bovine serum, which is far from an optimal component in cell culture,” says Maria Karlgren, whose pioneering work was recently recognised with the Björn Ekwall Memorial Award.

The possibility of administering drugs orally is appreciated by patients and improves treatment adherence. At the same time, many new drugs possess properties that complicate absorption via the intestine. Reliable methods to predict how potential drug candidates are absorbed in the body are therefore needed, and in October 2025 researchers at Uppsala University took an important step by demonstrating that foetal bovine serum (FBS), an established but ethically problematic component in cell culture, can be replaced with non-animal alternatives.

Forskning pågår vid Lab Karlgren

Research underway at Lab Karlgren

“There are established models for preclinical studies of drug candidates. However, both these and the models currently under development for studies of new classes of therapeutics rely on cultured cells. One common component in cell culture is FBS, which is extracted from foetuses obtained during the slaughter of pregnant cows. This is far from optimal, and we have now shown that the serum can be replaced with animal-free alternatives that provide equivalent or even improved results,” says Maria Karlgren, Associate Professor at the Department of Pharmacy.

The work is based on a medium developed at Lund University that enables cell culture entirely without animal-derived additives. The formulation is published and freely available, and by applying it to Caco-2 cell models, Karlgren’s group has demonstrated that cells cultured in this animal-free medium retain their characteristics and produce reproducible results.

“Today, FBS must be imported from countries that permit serum extraction. In addition, each batch possesses unique biological properties, making it more difficult to compare results, which is often essential in pharmaceutical research. Replacing this serum with a chemically defined alternative will save considerable resources to the benefit of science, healthcare and patients alike,” states Maria Karlgren.

Maria Karlgrens arbete har belönats med Björn Ekwall Memorial Award

Karlgren’s work was recognised with the Björn Ekwall Memorial Award

In spring 2026, Maria Karlgren received the Björn Ekwall Memorial Award for pioneering contributions to the development of animal-free testing methods. The award citation highlights Karlgren’s work to provide safer and more humane tools for studying toxicity in the human liver and intestine. Already in 2020, she received The Global 3Rs Award for her “innovative contributions to ethical science”.

“Our ambition is to develop and disseminate ethical, 3R-compatible models for drug development that generate reproducible results. Our recent advances are attracting considerable interest, and we are currently in dialogue with several groups interested in applying them in their own research. Receiving the Björn Ekwall Memorial Award is both an honour and a source of inspiration, but above all it helps raise awareness that high-quality animal-free alternatives to FBS do in fact exist.”

At the same time, some researchers still perceive barriers to transitioning to animal-free cell culture methods. One concern is the ability to compare future studies with previously published work. It is also sometimes argued that calf serum remains the more cost-effective option, although Maria Karlgren disagrees.

“When assessing the cost of calf serum, you must also take into account the resources required to locate a batch with properties comparable to those used previously, while the cost of components for animal-free cell culture continues to decrease. There must of course be access to quality-assured models. We are therefore currently preparing new projects aimed both at improving our existing results and at developing ethical models for additional stages of oral drug delivery research.”

Facts

  • Maria Karlgren’s group is part of Uppsala University’s research environment in Molecular Pharmaceutics.
  • The group’s work is funded through grants from, among others, Torvald and Britta Gahlin Foundation, Valborg Jacobsson Foundation and The Alternatives Research & Development Foundation.
  • The 3Rs stand for Replace, Reduce and Refine, and constitute an ethical and scientific framework governing all pharmaceutical research and animal experimentation within the European Union.

Contact

Maria Karlgren, Associate Professor
Department of Pharmacy
Maria.Karlgren@uu.se

text: Magnus Alsne, photo: Mikael Wallerstedt a o